1. Factor Therapeutics

2. Disclaimer

3. At a Glance

4. Our Technology : Molecular “Velcro” + Growth Factors

5. Advanced Wound Care Pipeline

6. VF001 Lead

7. VF001 Impact

8. Precision Wound Care – A World First

9. Setting the Trial up for success

10. Our Efficacy*

11. Target Population : Margolis “1” (Moderate) Significant Improvement

12. An Effective Market Segmentation Strategy

13. NCT02973893 : Phase II Trial Synopsis

14. Trial Progress

15. Label & Reimbursement

16. Poised for Clinical and Commercial Success

17. Catalysts